Expert Conversations: Caring for Patients With HCV and Coexisting Substance Use Disorders

Drs Stevan Gonzalez, Daniel Fierer, and Andrew Talal discuss their study on hepatitis C virus (HCV) and coexisting substance use disorder.

Section 1 - 0:45 (Gonzalez)

Section 2 - 4:50 (Fierer)

Section 3 - 19:06 (Talal)

Section 4 - 24:55 (Talal)

Final thoughts - 30:24 (Gonzalez)

Stevan A. Gonzalez, MD, is the medical director of Liver Transplantation in the Division of Hepatology at Baylor Simmons Transplant Institute in Fort Worth, Texas.

Daniel S. Fierer, MD, is an associate professor of medicine, infectious disease, at the Icahn School of Medicine at Mt. Sinai in New York, New York.

Andrew H. Talal, MD, MPH, is a professor in the Department of Medicine, Division of Gastroenterology, Hepatology, and Nutrition, at the Jacobs School of Medicine at the State University of New York at Buffalo in New York.

Reference:

• Gonzalez SA, Fierer DS, Talal AH. Medical and behavioral approaches to engage people who inject drugs into care for hepatitis C virus infection. Addict Disord Their Treat. 2017;16(2)Suppl. 1:S1-S23.  doi:10.1097/ADT.0000000000000104.